Royalty Pharma plc
Royalty Pharma plc is a United States-based company in the Healthcare sector with a market capitalisation of $26.8B. Its FinScore is 62/100; its highest-scoring layer is Momentum (86) and its lowest is Growth (40). The shares trade at 32.9x trailing earnings and are up 55% year to date.
Share price performance
About Royalty Pharma plc
www.royaltypharma.comRoyalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- HQ
- United States
- Fiscal year-end
- December
- Trading currency
- USD
- Reporting currency
- USD
- Fundamentals updated
- 75 days ago
- Market cap
- $26.8B
- Shares outstanding
- 445.3M
- P/E (TTM)
- 32.9x
- Dividend yield (TTM)
- 1.53%
- Beta (issuer)
- 0.41
- Revenue (latest FY)
- $2.4B
Revenue breakdown
- Financial Royalty Assets95.1%$2.3B
- Royalty Income, Other4.9%$117.0M
FinScore
As of 2026-10-20Snapshot
Ownership
As of 2026-06-30Sign up or log in to see Analysis
Analysis for Royalty Pharma plc is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Financials
Financials for Royalty Pharma plc is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Estimates
Estimates for Royalty Pharma plc is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Peers
Peers for Royalty Pharma plc is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Valuation
Valuation for Royalty Pharma plc is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see News
News for Royalty Pharma plc is available to Finryse members. The Overview stays open to everyone; creating an account is free.